XML 43 R31.htm IDEA: XBRL DOCUMENT v3.22.2
11. STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Mar. 31, 2022
STOCK-BASED COMPENSATION  
Summary of stock option activities

Weighted

Number of Shares

Average

Weighted

Shares

Underlying

Remaining

Average

Available for

Options

Contractual

Exercise

Intrinsic

    

Grant

    

Outstanding

    

Life (Years)

    

Price

    

Value

 

Balance at March 31, 2019

3,426,548

8,017,029

$

5.77

Granted

(1,011,708)

1,011,708

$

8.11

Exercised

(772,667)

$

4.39

$

2,614,879

Forfeited

107,474

(120,279)

$

7.03

Balance at March 31, 2020

2,522,314

8,135,791

$

6.17

Granted

(1,285,252)

1,285,252

$

6.46

Exercised

(667,503)

$

5.99

$

961,633

Forfeited

94,500

(320,663)

$

7.84

Balance at March 31, 2021

1,331,562

8,432,877

$

6.17

Options reserved

4,000,000

$

Granted

(1,280,761)

1,280,761

$

5.43

Exercised

(316,784)

$

5.12

$

149,937

Forfeited

484,862

(806,179)

$

6.45

Balance at March 31, 2022

4,535,663

8,590,675

5.39

$

6.07

Options vested and exercisable

5,499,074

3.77

$

5.86

$

133,784

Options vested and expected to vest

8,498,505

5.35

$

6.07

$

133,784

Schedule of options outstanding by exercise price

Number of

Options Outstanding

Options Exercisable

Shares

Weighted

Weighted Average

Weighted

Underlying

Average

Remaining

Number

Average

Options

Exercise

Contractual

Vested and

Exercise

Exercise Price

    

Outstanding

    

Price

    

Life (Years)

    

Exercisable

    

Price

 

$

3.40

-

4.81

1,013,655

$

4.12

3.58

822,845

$

4.04

$

4.98

-

4.99

1,050,501

$

4.99

3.82

1,050,501

$

4.99

$

5.13

-

5.58

1,410,456

$

5.42

6.37

630,915

$

5.24

$

5.59

-

5.83

1,167,427

$

5.76

5.57

535,873

$

5.70

$

5.91

-

6.70

1,431,119

$

6.43

5.44

828,589

$

6.36

$

6.86

-

7.26

985,648

$

7.08

4.05

985,648

$

7.08

$

7.40

-

7.88

726,606

$

7.61

7.69

398,243

$

7.63

$

8.06

157,210

$

8.06

7.85

78,604

$

8.06

$

8.09

82,160

$

8.09

5.83

82,160

$

8.09

$

8.30

565,893

$

8.30

7.26

85,696

$

8.30

8,590,675

$

6.07

5.39

5,499,074

$

5.86

Summary of stock-based compensation expense by line item

Year Ended March 31,

    

2022

    

2021

    

2020

 

(In thousands)

Cost of revenues

$

248

$

346

$

257

Research and development

1,676

1,509

1,487

Selling, general and administrative

1,069

999

822

Total

$

2,993

$

2,854

$

2,566

Schedule of weighted average assumptions

Year Ended March 31,

    

2022

    

2021

    

2020

 

Stock Option Plans:

Risk-free interest rate

0.66

-

1.62

%  

0.22

-

0.42

%  

1.35

-

2.30

%  

Expected life (in years)

5.00

5.00

5.00

Volatility

47.7

-

49.1

%  

41.9

-

47.6

%  

36.5

-

39.7

%  

Dividend yield

%  

%  

%  

Employee Stock Purchase Plan:

Risk-free interest rate

0.04

-

0.07

%  

0.12

-

0.15

%  

1.58

-

2.43

%  

Expected life (in years)

0.50

0.50

0.50

Volatility

45.6

-

57.4

%  

67.1

-

68.6

%  

33.5

-

43.1

%  

Dividend yield

%  

%  

%